Detalhe da pesquisa
1.
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
Am J Hematol
; 95(7): 799-808, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249963
2.
The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer.
J Urol
; 202(1): 96-101, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30933552
3.
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.
Hematol Oncol
; 36(1): 307-315, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219109
4.
Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients.
Br J Haematol
; 190(2): e89-e92, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453859
5.
Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.
EJHaem
; 4(3): 760-764, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601841
6.
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group.
JCO Precis Oncol
; 7: e2200400, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689697